Table 4.

CIVO for first early rivipansel treatment in OLE phase of study and early placebo treatment in RESET study

Overall population
OLE early rivipansel (n = 38)RESET early placebo (n = 46)
Median 1.83 3.79 
(Q1, Q3) (0.61, 5.15) (1.20, 9.06) 
Difference in medians (90% CI) −1.97 (−2.73 to 0.81) 
Ratio of medians (90% CI) 0.71 (0.37-1.34) 
P value  .2311 (NS) 
Overall population
OLE early rivipansel (n = 38)RESET early placebo (n = 46)
Median 1.83 3.79 
(Q1, Q3) (0.61, 5.15) (1.20, 9.06) 
Difference in medians (90% CI) −1.97 (−2.73 to 0.81) 
Ratio of medians (90% CI) 0.71 (0.37-1.34) 
P value  .2311 (NS) 
Adult population
OLE early rivipansel (n = 17)RESET early placebo (n = 23)
Median 3.45 4.99 
(Q1, Q3) (1.21, 14.88) (0.88, 9.49) 
Difference in medians (90% CI) −1.55 (−7.91 to 4.81) 
Ratio of medians (90% CI) 1.09 (0.39-3.04) 
P value  .9039 (NS) 
Adult population
OLE early rivipansel (n = 17)RESET early placebo (n = 23)
Median 3.45 4.99 
(Q1, Q3) (1.21, 14.88) (0.88, 9.49) 
Difference in medians (90% CI) −1.55 (−7.91 to 4.81) 
Ratio of medians (90% CI) 1.09 (0.39-3.04) 
P value  .9039 (NS) 
Pediatric population (age 6-17 y)
OLE early rivipansel (n = 21)RESET early placebo (n = 23)
Median 1.58 2.54 
(Q1, Q3) (0.61, 2.25) (1.20, 8.00) 
Difference in medians (90% CI) −0.96 (−2.93 to 1.01) 
Ratio of medians (90% CI) 0.48 (0.22-1.08) 
P value  .0718 
Pediatric population (age 6-17 y)
OLE early rivipansel (n = 21)RESET early placebo (n = 23)
Median 1.58 2.54 
(Q1, Q3) (0.61, 2.25) (1.20, 8.00) 
Difference in medians (90% CI) −0.96 (−2.93 to 1.01) 
Ratio of medians (90% CI) 0.48 (0.22-1.08) 
P value  .0718 

NS, not significant.

From analysis of covariance in rank-transformed values.

or Create an Account

Close Modal
Close Modal